Wednesday · November 18, 2026

 ·  Daily  ·  Newsletters

Resonance network: Quantum InsiderSpace Insider

Business & Markets · Startups

CGC Genomics Lands €1.7M to Advance AI Solutions in Cancer Genomics

CGC Genomics has announced the close of its €1.7 million pre-seed funding round to accelerate development of Qnomx, its GenAI-powered platform for regulatory-compliant cancer genomics interpretation. The round includes investment from Heal Capital, Labor Becker MVZ eGbR, better ventures, Superangels, Springboard Health Angels, JVH Ventures, and several individual backers.

Qnomx enables clinical laboratories to automate the manual review of complex genomic profiles, a key bottleneck in oncology diagnostics. By improving the speed and accuracy of cancer genomic data interpretation, CGC Genomics aims to reduce costs and streamline testing workflows. The company said the platform enhances decision-making and accelerates treatment timelines, ultimately helping physicians make faster, more informed therapy selections.

Featured image: Credit: CGC Genomics

James Dargan
About the author
James Dargan

James Dargan is a writer and researcher at The AI Insider. His focus is on the AI startup ecosystem and he writes articles on the space that have a tone accessible to the average reader.

The AI economy, every weekday morning

The daily briefing plus the weekly Scale-ups to watch edition. Free, no spam, unsubscribe any time.